Insilico signs US$888 million AI drug deal days after Hong Kong IPO
--------------------------------------------------------------------
Source: South China Morning Post
Published: 2026-01-05 15:46 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Property, Europe, Technology & AI, China, Drugs, Business & Economy
--------------------------------------------------------------------
Snippet:
Multi-year partnership with France’s Servier will use Insilico’s AI platform to explore novel cancer drugs
--------------------------------------------------------------------